Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Sinovac Acquires New Manufacturing Facility

publication date: Feb 15, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Sinovac Biotech (北京科兴生物制品有限公司) has acquired a medical manufacturing site and land use rights in the Changping area of Beijing. The site, which includes five buildings previously used to produce medical products, is about a half-hour’s drive from Sinovac’s existing Beijing facility. Sinovac will pay 120 million RMB ($17.6 million), of which 56.5 million RMB ($8.3 million) is due before February 20, 2010 with the balance to be paid over three years. More details...

Stock symbols: (NSDQ: SVA)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...